Lv3
294 积分 2025-06-29 加入
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series
4天前
已完结
SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
7天前
已完结
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases
10天前
已完结
An Improved Mouse Model of Atopic Dermatitis and Suppression of Skin Lesions by an Inhibitor of Tec Family Kinases
15天前
已完结
Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension
21天前
已完结
Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110)
25天前
已完结
Selective Targeting of STAT6: Recent Advances and Future Perspectives
25天前
已完结
PROTAC technology: clinical applications, future challenges, and innovative strategies
29天前
已关闭
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
1个月前
已完结
Longitudinal Phenotyping Studies of MRL/MpJ-Faslpr/J and NZBWF1/J Mouse Lupus Models
1个月前
已关闭